{
  "content": "Diagnosis:\t\tPancreatic adenocarcinoma\n\nManagement:\t\t12 Jan 2024 Whipple's procedure\n\nHistology:\t\tModerately differentiated pancreatic ductal adenocarcinoma\n\t\tpT3N1M0 (AJCC 8th Ed, Stage IIB)\n\t\tKEAP1 mutation detected\n\t\t2/18 lymph nodes positive\n\nCurrent situation:\tPost-operative follow-up\n\n[redacted name] attended clinic today following completion of 3 months adjuvant modified FOLFIRINOX chemotherapy. She has managed the treatment well with only grade 1 fatigue and mild peripheral neuropathy. Her performance status remains excellent at PS0. Recent CT scan on 15/4/24 shows no evidence of disease recurrence. Blood tests including CA19-9 are within normal range. The plan is to continue regular surveillance with 3-monthly CT scans and CA19-9 monitoring. Next clinic review arranged for July 2024 with repeat imaging.",
  "output": {
    "primary_cancer": {
      "site": "pancreas",
      "year": 2024,
      "month": 1,
      "metastases": null,
      "tnm_stage": "pT3N1M0",
      "other_stage": "Stage IIB",
      "histopathology_status": "moderately differentiated pancreatic ductal adenocarcinoma",
      "biomarker_status": "KEAP1 mutation detected",
      "cancer_timeline": [
        {
          "type": "treatment_surgery",
          "value": "Whipple's procedure",
          "year": 2024,
          "month": 1
        },
        {
          "type": "laboratory_finding",
          "value": "2/18 lymph nodes positive on surgical specimen",
          "year": 2024,
          "month": 1
        },
        {
          "type": "treatment_systemic_start",
          "value": "Started adjuvant modified FOLFIRINOX chemotherapy",
          "year": 2024,
          "month": 1
        },
        {
          "type": "anatomical_finding",
          "value": "CT scan shows no evidence of disease recurrence",
          "year": 2024,
          "month": 4
        },
        {
          "type": "laboratory_finding",
          "value": "CA19-9 within normal range",
          "year": 2024,
          "month": 4
        }
      ]
    },
    "other_cancers": [],
    "patient_facts": [
      {
        "type": "performance_status",
        "value": "PS0"
      },
      {
        "type": "current_symptom",
        "value": "grade 1 fatigue and mild peripheral neuropathy"
      }
    ],
    "status_updates": [
      {
        "type": "clinical_summary",
        "value": "Stage IIB pancreatic cancer post Whipple's procedure. Completed adjuvant modified FOLFIRINOX with good tolerance and no evidence of recurrence"
      },
      {
        "type": "latest_treatment_toxicity",
        "value": "grade 1 fatigue and mild peripheral neuropathy from chemotherapy"
      },
      {
        "type": "planned_investigation",
        "value": "3-monthly CT scans and CA19-9 monitoring"
      },
      {
        "type": "follow_up_referral",
        "value": "clinic review in July 2024 with repeat imaging"
      }
    ]
  }
}